NCT04067375View on ClinicalTrials.gov

Towards Routine HPA-screening In Pregnancy to Prevent FNAIT

CompletedOBSERVATIONAL
Enrollment

3,660

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

April 1, 2020

Study Completion Date

April 1, 2020

Conditions
Fetal and Neonatal Alloimmune Thrombocytopenia
Interventions
OTHER

Clinical data collection.

The following clinical data will be collected; maternal baseline characteristics, delivery related data, neonatal outcome, neonatal bleeding signs.

Trial Locations (1)

1066 CX

Stichting Bloedbank Sanquin, Amsterdam

All Listed Sponsors
collaborator

Sanquin Research & Blood Bank Divisions

OTHER

collaborator

Landsteiner Foundation for Blood Transfusion

OTHER

lead

Leiden University Medical Center

OTHER

NCT04067375 - Towards Routine HPA-screening In Pregnancy to Prevent FNAIT | Biotech Hunter | Biotech Hunter